Historical Prices for Welcure Drugs & Pharmaceuticals
Date | Open | Close | Daily High | Daily Low |
---|
Price change over selected period:
0%
0
Welcure Drugs & Pharmaceuticals Analyst Opinions
- All
- Buy
- Hold
- Sell
Date | Analyst | Rating | Price |
---|
Income Statements in Mio. INR
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 1.05 | 1.33 | 0.83 | 0.80 | 0.50 |
Change of sales in % | - | -100.00 | -21.23 | 61.58 | 3.77 | 59.00 | -44.19 |
Gross profit on sales | -0.36 | -0.03 | 1.03 | 1.32 | - | - | 0.47 |
Gross profit on sales change in % | -1,015.39 | - | -22.21 | - | - | - | - |
Operating income | -2.69 | 0.41 | 0.24 | 0.55 | -0.10 | 0.02 | -0.20 |
Operating income change in % | - | 74.33 | -57.00 | - | - | - | - |
Income before tax | -1.75 | 1.02 | 0.24 | 0.55 | -0.09 | 0.04 | -0.19 |
Income before tax change in % | - | 331.41 | -57.21 | - | - | - | - |
Income after tax | -1.75 | 1.02 | 0.24 | 0.55 | -0.09 | 0.04 | -0.19 |
Income after tax change in % | - | 331.41 | -57.21 | - | - | - | - |
Balance Sheet in Mio. INR
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total liabilities | 0.31 | 0.14 | 0.04 | 0.04 | 0.10 | 0.06 | 0.04 |
Long-term liabilities per share | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 13.40 | 15.88 | 0.93 | 14.63 | 0.14 | 14.17 | 14.13 |
Equity change in % | -15.61 | 1,607.76 | -93.64 | 10,147.27 | -98.99 | 0.28 | -1.35 |
Balance sheet total | 13.71 | 16.02 | 0.97 | 14.67 | 0.25 | 14.23 | 14.17 |
Balance sheet total change in % | -14.41 | 1,554.55 | -93.40 | 5,862.72 | -98.27 | 0.45 | -1.35 |
Key Data in INR
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Sales per share | - | 0.00 | 0.09 | 0.11 | 0.07 | 0.07 | 0.04 |
P/E ratio (year end quote, basic EPS) | - | 53.10 | 501.03 | 41.32 | - | 165.63 | - |
P/E ratio (year end quote, diluted EPS) | - | 53.10 | 501.03 | 41.32 | - | 165.63 | - |
P/E ratio (year end quote) | - | 53.10 | 501.03 | 41.32 | - | 165.63 | - |
Dividend yield in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity ratio in % | 97.77 | 99.15 | 96.06 | 99.75 | 58.05 | 99.57 | 99.75 |
Debt ratio in % | 2.23 | 0.85 | 3.94 | 0.25 | 41.95 | 0.43 | 0.25 |
Welcure Drugs Pharmaceuticals Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2024 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2023 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2022 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2021 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2020 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2019 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2018 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2017 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2016 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2015 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2014 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2013 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2012 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2011 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2010 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
2009 | Welcure Drugs & Pharmaceuticals Ltd Dematerialised | 0.00 | 0.00 | INR |
*Yield of the Respective Date
Welcure Drugs & Pharmaceuticals Profile
Welcure Drugs & Pharmaceuticals Ltd. engages in the manufacture and trade of pharmaceutical and medical products. The company was founded by Dharam Chand Jain on June 4, 1992 and is headquartered in New Delhi, India.